Ravn P, Madhurantakam C, Kunze S et al (2013) Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor
GLP-1 therapies, once niche treatments, are now central to managing diabetes and obesity
Yoshida K, Solomon DH, Kim SC
It is important to note that a weight plateau does not mean treatment failure
Patient and Prescriber Choice Choice of treatment needs to be directed by both the patient and the prescriber as their needs may be slightly different
Although some studies in people have shown hints that methylene blue may be beneficial for some brain-related issues, such as pain management and neuropsychiatric disorders, such studies to date have been small